AbbVie (LTS:0QCV) Cash Flow for Dividends : $-11,025 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is AbbVie Cash Flow for Dividends?

AbbVie's cash flow for dividends for the three months ended in Dec. 2024 was $-2,752 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $-11,025 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

AbbVie's quarterly payment of dividends increased from Jun. 2024 ($-2,750 Mil) to Sep. 2024 ($-2,751 Mil) and increased from Sep. 2024 ($-2,751 Mil) to Dec. 2024 ($-2,752 Mil).

AbbVie's annual payment of dividends increased from Dec. 2022 ($-10,043 Mil) to Dec. 2023 ($-10,539 Mil) and increased from Dec. 2023 ($-10,539 Mil) to Dec. 2024 ($-11,025 Mil).

AbbVie Cash Flow for Dividends Historical Data

The historical data trend for AbbVie's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Cash Flow for Dividends Chart

AbbVie Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

-7,716.00

-9,261.00

-10,043.00

-10,539.00

-11,025.00

AbbVie Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-2,626.00	-2,772.00	-2,750.00	-2,751.00	-2,752.00

AbbVie Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11,025 Mil.

AbbVie Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of AbbVie's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (LTS:0QCV) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 4AB:Germany ABBVCL:Chile ABBV:Canada ABBV34:Brazil 4AB:Bulgaria ABBV:Austria ABBV:Argentina

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

https://www.abbvie.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

AbbVie Headlines

No Headlines